Inhibition of PKCδ Reduces Amyloid-Β Levels and Reverses Alzheimer Disease Phenotypes

Journal of Experimental Medicine - United States
doi 10.1084/jem.20171193
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Pioglitazone Reduces Β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Self-Propagative Replication of Amyloid-Β Oligomers in Alzheimer Disease

Biophysical Journal
Biophysics
2015English

Inhibition of Alzheimer Β-Peptide Fibril Formation by Serum Amyloid P Component

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Pyroglutamate Amyloid-Β (Aβ): A Hatchet Man in Alzheimer Disease

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Amyloid-Β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Cross-Interactions Between the Alzheimer Disease Amyloid-Β Peptide and Other Amyloid proteins.A FURTHER ASPECT OF THE AMYLOID CASCADE HYPOTHESIS.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Amyloid Β and Alzheimer Disease Therapeutics: The Devil May Be in the Details

Journal of Clinical Investigation
Medicine
2003English

Glyceraldehyde-3-Phosphate Dehydrogenase Aggregates Accelerate Amyloid-Β Amyloidogenesis in Alzheimer Disease

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Sleep and Β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy